About Brian Kotzin
Brian Kotzin filed with the SEC as director of Biora Therapeutics from 2020 to 2024.
Form D filings name Brian Kotzin as a director at Kyverna Therapeutics.
Brian Kotzin reports to the SEC as a director of 3 public companies, including Rigel Pharmaceuticals (RIGL) and Kyverna Therapeutics (KYTX).
Brian Kotzin first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Brian Kotzin in the role, so the role may have started earlier or lasted longer.
BI
Biora Therapeutics, Inc.
Director
2020 – 2024 · Public company (BIOR)
RI
Rigel Pharmaceuticals Inc.
Director
2017 – 2024 · Public company (RIGL)
Key Colleagues at Startups
The people Brian Kotzin works with at each company, as listed on that company's latest Form D.
Kyverna Therapeutics, Inc. · Form D, Nov 7, 2023
IC
Ian Clark
Director
RJ
Ryan Jones
Chief Financial Officer
KW
Karen Walker
Executive officer
PM
Peter Maag
Executive officer and director
JC
James Chung
Executive officer
DS
Dan Spiegelman
Director
BS
Beth Spiegelman
Director
FC
Fred Cohen
Director
SL
Steve Liapis
Director
DB
Dominic Borie
Executive officer